- $71.05m
- $73.38m
- $77.44m
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 15.2 | 19 | 27.4 | 78.7 | 77.4 |
Cost of Revenue | |||||
Gross Profit | 4.83 | 6.37 | 4.96 | 0.843 | -26.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 40.5 | 40.2 | 136 | 185 | 230 |
Operating Profit | -25.3 | -21.2 | -108 | -106 | -153 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -25.7 | -21.8 | -107 | 7.97 | -135 |
Provision for Income Taxes | |||||
Net Income After Taxes | -25.7 | -21.8 | -107 | 7.97 | -135 |
Net Income Before Extraordinary Items | |||||
Net Income | -25.7 | -21.8 | -107 | 7.97 | -135 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -25.7 | -8.76 | -107 | 7.97 | -135 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.14 | -0.048 | -0.963 | 0.039 | -0.586 |
Dividends per Share |